Neonatal Patients

In the United States, about 4,800 (or 11.6 per 10,000) babies are born every year with critical congenital heart defects (CCHD). These babies are at significant risk if this condition goes undiagnosed.¹

CCHD guidelines recommend using motion-tolerant pulse oximeters.

Nellcor™ pulse oximetry has been shown to be a simple and economical tool to aid healthcare providers in CCHD screening.²

Nellcor™ pulse oximetry monitors are designed to meet your CCHD screening needs. We are the only company to receive FDA clearance for a motion-tolerant bedside pulse oximeter portfolio that is also compliant with ISO 80601-2-61 (International Organization for Standardization) standards for pulse oximetry.

1. Centers for Disease Control and Prevention. Pulse Oximetry Screening for Critical Congenital Heart Defects. Available at: http://www.cdc.gov/ncbddd/pediatricgenetics/CCHDscreening.html. Walsh, W., Evaluation of pulse oximetry screening in Middle Tennessee: cases for consideration before universal screening. J Perinatol, 2011 Feb. 31(2): p. 125-9.
2. NCT01720355 at ClinicalTrials.gov

Country Office

Level 3 - Building 5

Central Corporate Centre

666 Great South Road

Penrose, Auckland

New Zealand

Select your country/language

Neonatal Patients

In the United States, about 4,800 (or 11.6 per 10,000) babies are born every year with critical congenital heart defects (CCHD). These babies are at significant risk if this condition goes undiagnosed.¹

CCHD guidelines recommend using motion-tolerant pulse oximeters.

Nellcor™ Pulse Oximetry

Pre Hospital Patients

High Risk Patients

Low Perfusion Patients

About Medtronic

Minimally Invasive Therapies

Country Office

©2025 Medtronic

Select your country/language

Minimally Invasive Therapies / Products / Pulse Oximetry / Nellcor™ Facts / Patients / Neonatal Patients

Neonatal Patients

In the United States, about 4,800 (or 11.6 per 10,000) babies are born every year with critical congenital heart defects (CCHD). These babies are at significant risk if this condition goes undiagnosed.1

CCHD guidelines recommend using motion-tolerant pulse oximeters.

Nellcor™ Pulse Oximetry

Pre Hospital Patients

High Risk Patients

Low Perfusion Patients

About Medtronic

Minimally Invasive Therapies

Country Office

©2025 Medtronic

In the United States, about 4,800 (or 11.6 per 10,000) babies are born every year with critical congenital heart defects (CCHD). These babies are at significant risk if this condition goes undiagnosed.¹